Doug Kiehl
Senior Director: Disruptive/Transformative Technologies Team (Dt3) And Digital Twin Coe @ Eli Lilly and Company
About Doug Kiehl
Doug Kiehl serves as the Senior Director of the Disruptive/Transformative Technologies Team and Digital Twin Center of Excellence at Eli Lilly and Company, where he has worked since 2022. He has extensive experience in mass spectrometry and biocompatibility, having previously held leadership roles at Eli Lilly and participated in various expert panels and committees in the field.